Sustained local application of epidermal growth factor to accelerate reepithelialization of tracheal grafts  Jinbo Zhao, MD, Yong Han, MD, Zhibo Liang,

Slides:



Advertisements
Similar presentations
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Advertisements

Manuel J. Antunes, MD, PhD, DSc 
Rounding numbers The Journal of Thoracic and Cardiovascular Surgery
Wen-Jian Jiang, MD, Jin-Hua Li, MD, Jiang Dai, MD, Yong-Qiang Lai, MD 
Tracheal regeneration: Evidence of bone marrow mesenchymal stem cell involvement  Agathe Seguin, MD, PhD, Sonia Baccari, MD, Muriel Holder-Espinasse, MD,
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
Right internal thoracic artery or saphenous vein grafting
Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Abracadabra I, II…HeartMate 3?
Exposed thoracic aortic endovascular stent graft
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
Multilevel data analysis: What? Why? How?
How should we treat air leaks?
Bicuspid aortic valve aortopathy: One size fits all?
The lord of the rings  Antonio Miceli, MD, PhD 
Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery  Pedro J.
The variability of the mitral valve anatomy and terminology
Yang Zhang, MD, Haiquan Chen, MD, PhD 
Successful allotransplantation of cryopreserved tracheal grafts with preservation of the pars membranacea in nonhuman primates  Tomohiro Murakawa, MD,
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Support Your Specialty
Innovation and science: The future of valve design
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Bartley P. Griffith, MD, FACS, FRCS 
Military surgeons just want to have fun
Do we need a bibliometrician to know which way the wind is blowing?
A first start for lung transplantation?
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
A fate worse than death  Jennifer S. Lawton, MD 
Attachment disorder in thoracoabdominal surgery
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
The thoracoabdominal saga and heroes
Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD 
Functional tricuspid pathology: To treat or not to treat
The harder one looks, the more one finds
Jason J. Han, MD, Pavan Atluri, MD 
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Keep it short and sweet  Ian A. Makey, MD, Scott B. Johnson, MD 
The future of cardiac surgery training: A survival guide
The continuing challenge of congenital heart disease in China
External tracheal stenting for pediatric airway obstruction: A word of caution  Roosevelt Bryant, MD  The Journal of Thoracic and Cardiovascular Surgery 
Hongcan Shi, MD, PhD, Hong Xu, MD, Dan Lu, MD, Jun Wu, MD 
Bicuspid aortopathy: Seeing the forest for the trees
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
Commentary: Judgment day: Should you add atrial fibrillation ablation?
Toward a more rational approach in treating type B aortic dissection
Evaluating the best approach to treatment of aortic stenosis: The jury is still out  Glen B. Taksler, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Apples remain apples NO matter what
Respect the aorta The Journal of Thoracic and Cardiovascular Surgery
Preoperative PFTs: The answer is blowing in the wind
Sunjay Kaushal, MD, PhD, Brody Wehman, MD 
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Did you like Terminator 3 better than Terminator 2
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Carl L. Backer, MD, Bradley S. Marino, MD, MPP, MSCE 
Journal changes and initiatives
Lessons learned from Melody valve retrieved at transplantation
Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks!  W. Hampton Gray, MD, P. Michael.
Akiko Tanaka, MD, PhD, Takeyoshi Ota, MD, PhD 
Deciding how much to pay for effective care
Presentation transcript:

Sustained local application of epidermal growth factor to accelerate reepithelialization of tracheal grafts  Jinbo Zhao, MD, Yong Han, MD, Zhibo Liang, MD, Zhipei Zhang, PhD, Qiang Lu, MD, Xiaolong Yan, MD, Xiaofei Li, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 140, Issue 1, Pages 209-215 (July 2010) DOI: 10.1016/j.jtcvs.2009.10.036 Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Characteristics of epidermal growth factor–loaded gelatin microspheres in vitro were examined with scanning electron microscopy (A), and their degradation in vivo was examined with light microscopy (B–F, original magnification ×50). A, Microspheres looked round and regular and were well dispersed in vitro. B through D, microspheres had no distinguishable change in structure or appearance in vivo for 21 days after application. B, Day 7; C, day 14; D, day 21. E, Thirty-five days after application in vivo, most microspheres had lost structure and been degraded. F, Fifty-two days after transplant, microspheres were totally disintegrated. The Journal of Thoracic and Cardiovascular Surgery 2010 140, 209-215DOI: (10.1016/j.jtcvs.2009.10.036) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 State of tracheal epithelium was evaluated by epithelium score. Epithelium score of group treated with epidermal growth factor–loaded gelatin microspheres (EGF-GMs) was higher than scores of groups treated with epidermal growth factor (EGF), gelatin microspheres (GMs), or nothing (Control) on days 35 and 52 after transplant. Error bars represent SD. The Journal of Thoracic and Cardiovascular Surgery 2010 140, 209-215DOI: (10.1016/j.jtcvs.2009.10.036) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Thirty-five days after transplant, scanning electron microscopy showed dense population of ciliated epithelium in epidermal growth factor–loaded gelatin microsphere group (A), with sparse populations of blunted cilia with interspersed mucous cells in other groups. B, Epidermal growth factor group; C, gelatin microsphere group; D, control group. The Journal of Thoracic and Cardiovascular Surgery 2010 140, 209-215DOI: (10.1016/j.jtcvs.2009.10.036) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Fifty-two days after transplant, scanning electron microscopy showed epithelium in epidermal growth factor–loaded gelatin microsphere group (A) to be intact, well differentiated, and functional, whereas epithelial cells were relatively sparse in other groups. B, Epidermal growth factor group; C, gelatin microsphere group; D, control group. The Journal of Thoracic and Cardiovascular Surgery 2010 140, 209-215DOI: (10.1016/j.jtcvs.2009.10.036) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Subepithelial fibrosis was evaluated by ratio of lamina propria to tracheal cartilage (LCR). On days 7, 14, and 21 after transplant, there was no statistically significant difference among groups. Ratio of group treated with epidermal growth factor–loaded gelatin microspheres (EGF-GMs) was lower than ratios of groups treated with epidermal growth factor (EGF), gelatin microspheres (GMs), or nothing (Control) on days 35 and 52. Error bars represent SD. The Journal of Thoracic and Cardiovascular Surgery 2010 140, 209-215DOI: (10.1016/j.jtcvs.2009.10.036) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions